EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.
about
EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with SnapinAssociation between RCAS1 expression and clinical outcome in uterine endometrial cancerThe association between RCAS1 expression in laryngeal and pharyngeal cancer and its healthy stroma with cancer relapse.Novel serum tumor marker, RCAS1, in pancreatic diseasesSelection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines.Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.The impact of T-cell immunity on ovarian cancer outcomes.RETRACTED: Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells.Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma.EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytesExtracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression.Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer.
P2860
Q24556574-FA258242-1D9B-4AC5-A6CF-4E2B1234D8C7Q24651134-1C0CE065-F04C-4B11-9316-5007C0D1C8C2Q33403620-6C8BE848-E8CA-45B9-B7BF-BCAB6F50241BQ35059725-0DBE33C7-B485-4096-B867-F330C3B0D328Q35139632-E59814DF-A71F-4CCB-A8DB-B796560C7F94Q36209749-9D78D81F-E917-4819-BB41-040DB140F977Q36694163-1505F084-DE92-4E5C-B50B-DCA5E001ED53Q37118142-530AECD7-BA56-495B-B0E7-E92E941F9454Q37129445-D66C8EAE-EF77-4178-800B-3E3D62675277Q37644981-A10C83EA-6C07-4847-AB3B-ED28A2EA7AAFQ39850984-77EA9814-0F06-4542-97B3-6830C5701516Q42536212-68B0FA29-CC18-4362-8FDA-CC899BBE0291Q49838785-1EB315FA-AC3A-4024-A258-1302E5051A73Q51829383-0E26FE6C-DDBE-4072-8180-4C9A971EB640
P2860
EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
EBAG9/RCAS1 in human breast ca ...... endocrine-immune interactions.
@ast
EBAG9/RCAS1 in human breast ca ...... endocrine-immune interactions.
@en
type
label
EBAG9/RCAS1 in human breast ca ...... endocrine-immune interactions.
@ast
EBAG9/RCAS1 in human breast ca ...... endocrine-immune interactions.
@en
prefLabel
EBAG9/RCAS1 in human breast ca ...... endocrine-immune interactions.
@ast
EBAG9/RCAS1 in human breast ca ...... endocrine-immune interactions.
@en
P2093
P2860
P356
P1476
EBAG9/RCAS1 in human breast ca ...... endocrine-immune interactions.
@en
P2093
Kawabata W
Muramatsu M
Tsuchiya F
P2860
P2888
P304
P356
10.1054/BJOC.2001.2176
P407
P577
2001-11-01T00:00:00Z
P5875
P6179
1001226558